Mounjaro

By Mrinalika Roy and Mariam Sunny Aug 5 (Reuters) – Sales of Eli Lilly’s Zepbound and Mounjaro injectable…

Novo Nordisk shares tumbled Tuesday after the Danish pharmaceutical giant released updated financial guidance that, while improved from…

Novo Nordisk (Photo: Reuters) 1 min read Last Updated : Jul 25 2026 | 12:26 AM IST …

A lawsuit, filed today in federal court, challenges a nationwide pattern of deceptive advertising which confuses consumers by…

Two global pharmaceutical companies that manufacture GLP-1 class obesity treatments have signaled a looming legal battle. Provided by…

Topline Ozempic drugmaker Novo Nordisk sued rival GLP-1 manufacturer Eli Lilly in federal court Tuesday, accusing the company…

New Delhi: In a fresh escalation of the battle for dominance in the fast-growing GLP-1 drug market, Novo…

Novo Nordisk just hauled Eli Lilly into federal court, accusing its chief obesity-drug rival of juicing sales…

Novo Nordisk has escalated its battle with chief rival Eli Lilly by filing a federal lawsuit accusing the…

Novo Nordisk NVO announced new real-world findings showing that adults with type II diabetes (T2D) who escalated from Ozempic…

Novo Nordisk NVO announced new real-world findings showing that adults with type II diabetes (T2D) who escalated from Ozempic…

Jun 6, 2026 The pharmaceutical sector is defined by intense rivalry and a constant push for new treatments.…

Lilly’s Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk